MAPK8 and cancer: We used treatment with the selective JNK inhibitor JNK-IN-8 (Zhang et al., 2012) to interfere with overall JNK signaling, which indeed prevented phosphorylation of cJUN in WT and cancer cells (Figures 6G–6I).